Division of Hematology and Oncology
Breast Cancer Risk Reduction, Breast Cancer Treatment, Head and Neck Cancer
University of Tennessee, Memphis, 1983
Internal Medicine, University of Massachusetts in Worchester Memorial Hospital, Massachusetts, 1986
Hematology/Oncology, Duke University Medical Center, North Carolina, 1989
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
Pannell TA, Panella TJ, Zaretzki RL.
The prognostic impact of determining treatment plans based on discordant metastatic tumor receptors on relapse. American Journal of Hematology / Oncology. 2016;12(9):14-20.
Orucevic A, Curzon M, Curzon C, Heidel RE, McLoughlin JM, Panella T, Bell J.
Breast cancer in elderly Caucasian women-An institution-based study of correlation between breast cancer prognostic markers, TNM stage, and overall survival. Cancers. 2015 Jul 31;7(3):1472-83.
Ranganath HA, Panella TJ.
Administration of ipilimumab to a liver transplant recipient with unresectable metastatic melanoma. Journal of Immunotherapy. J Immunother. 2015 Jun;38(5):211.
Orucevic A, Chen J, McLoughlin JM, Heidel RE, Panella T, Bell J.
Is the TNM staging system for breast cancer still relevant in the era of biomarkers and emerging personalized medicine for breast cancer - An institution's 10-year experience. The Breast Journal . 2015 Mar;21(2):147-54.
Orucevic A, Curzon M, McLoughlin J, Geddam C, Heidel RE, Desai P, Panella T, Bell J. Breast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience. Presented at World Congress on Breast Cancer; 2015 Aug 3-5; Birmingham, United Kingdom.Top
The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290
Copyright © 2018